/Investor DB

quadraScope Venture Fund — Full Portfolio

12 tracked investments · listed companies and verified rows first

ADvantage Therapeuticsadvantagetherapeutics.com𝕏

ADvantage Therapeutics is a biopharmaceutical company engaged in therapeutic drug development and clinical research, including NIH/PHS-funded studies evaluating the safety and effectiveness of drugs and treatments.

BiotechHealthtechMiami, US

Agustin Fernandez Santana III(Executive Officer, Director)Jeffrey B. Madden(Executive Officer, Director)inDavid Buchsbaum(Executive Officer)Frank Mattner(Director)David A. Buchsbaum(Chief Financial Officer)

BoardWalter Schmidt(Director)

Alden Scientificaldenscientific.comin

Alden Scientific is a biotech company with over 40 scientists, bioinformaticians, engineers, clinicians, and researchers developing immunological research capabilities.

AI & Machine LearningBiotechDigital HealthCambridge, US

James Heywood(CEO & Founder)

Co-investorsDeep FutureiSelect FundService Provider Capital

Biochangebiochange.lifein

BioChange develops CellFoam, a biodegradable and biocompatible foam scaffold technology for regenerative medicine that supports tissue repair and organ recovery.

BiotechHealthtechMedical Devices

Iris Shichorin

bioiobioio.techin𝕏

BIOIO develops a genetics-based platform for elucidating drug mechanisms of action, combining decades of research in pharmacology with big data and automation to accelerate drug discovery and development.

AI & Machine LearningBiotechDeep TechLongevity

Dr. Peterson

Co-investorsBioGenerator VenturesLifespan Vision VenturesMissouri Technology Corporation

Cosmicacosmica.bio

Cosmica builds OrganAge™, a blood-based biomarker tool that scores biological aging across nine physiological systems, and an intervention engine that ranks foods, supplements, and activities by how they act on a person's aging-related genes.

BiotechDigital HealthLongevity

David Furman(Founder & Chief Executive Officer)Abhay Saini(Co-founder & Chief Operating Officer)inFei Wu(Chief Scientific Officer)

Deciduous Therapeuticsdeciduoustx.cominJun 2019

Deciduous Therapeutics develops small molecule and immunomodulatory therapies targeting senescent cells to treat age-related diseases including Type 1 diabetes, autoimmunity, and metabolic disorders.

BiotechDigital HealthLongevitySan Francisco, US

Robin Mansukhani(CEO and Co-Founder)inAnil Bhushan(Scientific Founder)in

BoardDylan Morris(Director)in

Co-investorsage1Bold Capital PartnersCornucopian Capital ManagementCRV (Charles River Ventures)Formic VenturesGaingels+5 more

Healthy Longevity Clinichealthylongevity.clinicin

A clinic offering personalized longevity medicine programs designed to extend healthspan through scientifically-proven interventions, combining advanced diagnostics and therapies sourced from cutting-edge research.

Digital HealthHealthtechLongevityWellness & FitnessMiami, US

Petr Sramek(Co-founder & Managing Partner)

Immunis Biomedicalimmunisbiomedical.cominMay 2026

Immunis Biomedical develops multi-active biologics based on stem cell-derived secretomes — cell-free therapeutics containing proteins, lipids and growth factors — aimed at treating age-related and immune-related diseases.

BiotechHealthtechLongevityIrvine, US

Gabriel Nistor(Executive Officer)

BoardTakahide Koda(Director)Daniel Kraft(Director)inHans Keirstead(Chairman of the Board)

Co-investorsBold Capital PartnersJLSLifespan Vision VenturesRemiges Ventures, Inc.

Repair Biotechnologiesrepairbiotechnologies.comin

Repair Biotechnologies develops the Cholesterol Degrading Platform, a therapeutic approach for treating conditions caused by localized accumulations of excess cholesterol.

BiotechHealthtechMedical DevicesSyracuse, US

Guilherme Cherman Perdigao de Oliveira(Executive Officer, Director)Reason("CEO's full legal name is ""Reason""")Anthony Matthew Chow(Director)

BoardKelsey Moody(Director)

Co-investorsLong GameMethuselah FoundationThynk Capital

Vincere Biosciencesvincerebio.comin𝕏

Vincere Biosciences develops small-molecule therapeutics targeting mitochondrial quality control and mitophagy, primarily for neurodegenerative diseases including Parkinson's disease.

AI & Machine LearningBiotechDeep TechLongevity

Co-investorsAlumni VenturesBeiersdorf Innovation FundBeresford VenturesDraper AssociatesFreemind InvestmentsLong Game+1 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Matter BioNanotics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.